Cord Blood Transplants: Good or Bad?
Save the Cord Foundation and WellSky are proud to welcome Filippo Milano, M.D, Ph.D. from the Fred Hutchinson Cancer Research Center for our next edition of Share the Science on Thursday, March 28th, 2019.
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.
What would you do?
You are a doctor. A cancer patient comes to you and you advise a stem cell transplant. This news brings hope and nervousness to you both. Both of you know that it can be impossible sometimes to find a bone marrow stem cell donor who meets all of the matching criteria and is available/willing to help. But, wait. . . why limit yourself to using bone marrow stem cells? Public stem cell registries around the world can also provide access to cord blood stem cells. They are easier to match and readily available. A cord blood transplant could be a wonderful solution for your patient. But, don't take our word for it. Let the science guide you. Dr. Milano will give you the facts you need.
Does cord blood have advantages?
It has been decades since the first cord blood transplant. Since that milestone moment in 1988, the medical establishment has come to recognize cord blood as a viable source of stem cells. Currently, there are over 80 different life-threatening diseases for which cord blood is used as treatment. Included on this list of diseases are many blood cancers, leukemia, lymphoma and sickle cell anemia. Yet, for many doctors and transplant centers, the use of cord blood as a source of stem cells is often seen as a last resort. Should it be? Is it really a last resort or is it a better choice? The answer undoubtedly depends on many factors.
Dr. Filippo Milano is a world-renowned stem cell transplant expert specializing in cord blood transplants. For years, he has helped cancer patients via his role at the Fred Hutchinson Cancer Research Center or "The Hutch," as it is often called. As the Associate Director of the Cord Blood Transplantation program at "The Hutch," Dr. Milano has been particularly focused on ways to increase the number of patients eligible for a cord blood transplant via improved clinical practices. His work has been focused on making improvements that would ultimately lead to better clinical outcomes for cord blood recipients and translate to a better quality of life post-transplant.
SHARE THE SCIENCE
Dr. Filippo Milano
from the Fred Hutchinson Cancer Research Center
"Clinical Outcomes for Cord Blood Transplants"
Free webinar. Open to the public.
Thursday, March 28th, 2019 - 11am Central Time
About the Speaker
In 2016, Dr. Milano and his colleagues at Fred Hutchinson Cancer Research Center (Fred Hutch) published the results of their ground-breaking study, "Cord-Blood Transplantation in Patients with Minimal Residual Disease" in the New England Journal of Medicine. The study concluded ". . . the probability of overall survival after receipt of a transplant from a cord-blood donor was at least as favorable as that after receipt of a transplant from an HLA-matched unrelated donor and was significantly higher than the probability after receipt of a transplant from an HLA-mismatched unrelated donor. Furthermore, the probability of relapse was lower in the cord-blood group than in either of the other groups." These results brought hope to many.
At Fred Hutchinson Cancer Research Center, Dr. Milano is an Assistant Member of the Clinical Research Division, and Associate Director Cord Blood Transplantation Cord Blood Program. He is also an Assistant Professor at the University of Washington.
Dr. Milano received his MD (2001) and his PhD in Medicine (2010) from the University “La Sapienza” Rome.
We wish to thank Dr. Milano for volunteering his time to speak on
Share the Science and sharing his valuable insight on the cord blood transplants.
We also wish to thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Comments are closed.
Write something about yourself. No need to be fancy, just an overview.